comparemela.com

Latest Breaking News On - European society for paediatric infectious diseases - Page 1 : comparemela.com

GSK s five-in-one meningococcal vaccine candidate shows promise in phase 3 trial

GSK s five-in-one meningococcal vaccine candidate shows promise in phase 3 trial
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Sanofi Reports Data Showing RSV Drug Protects Infants in Real-World Conditions

The antibody drug, nirsevimab, is designed with a long half-life intended to protect infants from respiratory syncytial virus infection through the entire season. The drug, co-developed by AstraZeneca and Sanofi, is under FDA review.

Few children affected by monkeypox so far – but risks are higher in children 8 or younger

Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.